Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: web + 0.38 + 33,900  Related to the article below (Last Update: 8/5/2008)

Altra Holdings Announces Record Financial Results for the Second ...
MarketWatch -
Also, the company has posted slides on its web site at http://www.altramotion.com in the Investor Relations Section in the Events & Presentations tab to ...AIMC

Earthtimes (press release)
Hampton Roads Bankshares Announces Second Quarter Financial ...
FOXBusiness - Aug 2, 2008
On June 30, 2008, the nonperforming assets to total assets ratio was 0.38%, up slightly from the comparable period last year when the Company had no loans ...
Peapack-Gladstone Financial Corporation Reports 27% Increase in ... MarketWatch
Banner Corporation Announces Second Quarter Results; Includes ... MarketWatch
all 994 news articles »  HMPR - PGC - BANR
GFI Group Inc. Announces Second Quarter 2008 Results; Declares ...
MarketWatch - Jul 31, 2008
A live audio web cast of the conference call will be available on the Investor Relations section of GFI's Web site. For web cast registration information, ...GFIG
First Citizens Reports Earnings for Second Quarter 2008
MarketWatch - Jul 28, 2008
Net charge-offs totaled $10.4 million or 0.38 percent of average loans and leases during the second quarter of 2008 compared to $4.0 million or 0.16 percent ...
Ness Technologies Announces Record Second Quarter 2008 Financial ...
IT News Online, India - Jul 29, 2008
0.11 $ 0.21 $ 0.25 $ 0.38 Weighted average number of shares (in thousands) used in computing basic net earnings per ...NSTC

Blocks & Files
Dynamics Research Corporation Reports Second Quarter 2008 Results
Earthtimes (press release), UK - Jul 31, 2008
The call will be available via telephone at (877) 741-4251, and accessible via Web cast at www.drc.com. Recorded replays of the conference call will be ...
Stratasys Reports Record Second Quarter Financial Results Trading Markets (press release)
all 308 news articles »  SSYS - DRCO
Mexico?s inflation accelerates more than forecast
Tehran Times, Iran - Jul 25, 2008
Inflation was 0.38 percent in the first half of July, the central bank said on its Web site. Economists expected consumer prices to rise 0.25 percent, ...
Littelfuse Reports Second Quarter Results
MarketWatch - Jul 30, 2008
The call will be broadcast live over the Internet and can be accessed through the company's Web site: www.littelfuse.com. Listeners should go to the Web ...LFUS
First Stump Delivery Arrives on Schedule
FOXBusiness - Aug 1, 2008
CONTACT INFORMATION Corporate Inquiries: Kevin Hull or Alan Campbell (604) 685-2222 Email: Email Contact Or visit Klondike Silver's web-site: ...CVE:KS - PINK:KLSVF - TSE:X
Partner Communications Reports Second Quarter 2008 Results
MarketWatch - Jul 31, 2008
The Board has approved the distribution of a dividend for Q2 2008 of NIS 1.26 (US$ 0.38) per share (in total approximately NIS 200 million or US$ 60 ...PTNR
Source: Google News

Investigation of web stresses in reinforced concrete beams:: part II, restrained beams -
FE Richart, LJ Larson - ideals.uiuc.edu
... sponding values of the stress ratio become 0.38, 0.48, and ... TESTS OF RESTRAINED BEAMS,
SERIES OF 1917 WEB STRESSES IN ... 155 6a/45? 8 /85400 49400 33900 458 475 ...

Synthesis of meso-? doubly linked porphyrin tapes -
A Tsuda, Y Nakamura, A Osuka - Chemical Communications, 2003 - rsc.org
... First published on the web 7th April 2003. ... max ( ) of 3a: 411 (57900), 498 (33900),
531 (35400), and 741 ... the number of the porphyrins (0.44 V for 3b, 0.38 V for ...
-

Synthesis of meso-b doubly linked porphyrin tapes
A Tsuda, Y Nakamura, A Osuka - rsc.org
... First published as an Advance Article on the web 7th April ... of the porphyrins (0.44
V for 3b, 0.38 V for 3c ... l max (e) of 3a: 411 (57900), 498 (33900), 531 (35400 ...

Two-dimensional gel protein database of Saccharomyces cerevisiae
F Bordeaux, B MolCculaire, CEA Saclay - Electrophoresis, 1996 - doi.wiley.com
... In all, 600 spots are annotated. These data can be accessed on the Yeast Protein
Map server through the World Wide Web network. 1 Introduction ...
-

[PDF] A1. 0 Introduction -
A Table - indiana.gov
Page 1. Appendix 1 Default Closure Tables IDEM RISC Technical Guide ? Appendix
1 (January 31, 2006 Update) A.1-1 A1.0 Introduction ...

Design of a Herpes Simplex Virus Type 2 Long Oligonucleotide-Based Microarray -
DP Infection - DNA Viruses: Methods And Protocols, 2005 - Springer
Page 1. 423 From: Methods in Molecular Biology, vol. 292: DNA Viruses: Methods and
Protocols Edited by: PM Lieberman ? Humana Press Inc., Totowa, NJ 28 ...
-

[PDF] RCRA FACILITY INVESTIGATION (RFI) WORK PLAN ADDENDUM NO. 3 -
I BEDFORD - bedfordpowertraincorrectiveaction.com
... Associates 651 Colby Drive Waterloo, Ontario Canada N2V 1C2 Office: (519)
884-0510 Fax: (519) 884-0525 web: http:\\www.CRAworld.com ...

The structure and development of a wing-tip vortex -
WJ Devenport, MC Rife, SI Liapis, GJ Follin - Journal of Fluid Mechanics Digital Archive, 2006 - Cambridge Univ Press
Page 1. J. Fluid Mrch. (1996). tiol. 312, pp. 67-106 Copyright 0 1996 Cambridge
University Press 67 The structure and development of a wing-tip vortex ...

Privatization in the Kyrgyz Republic
WW Jermakowicz, J Pankow - Russian and East European Finance and Trade, 1995 - case.com.pl
Page 1. CASE - Center for Social and Economic Research PRIVATIZATION IN THE KYRGHYZ
REPUBLIC by Wladyslaw W. Jermakowicz University of Southern Indiana ...

[PDF] A GUIDE TO SELECTED ALGORITHMS, DISTRIBUTIONS, AND DATABASES USED IN EXPOSURE MODELS DEVELOPED BY … -
T Johnson, EPAGN CR827033, USEP Agency - 2001 - earth1.epa.gov
Page 1. A GUIDE TO SELECTED ALGORITHMS, DISTRIBUTIONS, AND DATABASES USED IN EXPOSURE
MODELS DEVELOPED BY THE OFFICE OF AIR QUALITY PLANNING AND STANDARDS by ...

Source: Google Scholar
 

Percutaneous radiofrequency ablation of liver tumors prove safe and effective

Percutaneous imaging guided radiofrequency ablation (RFA) of hepatocellular carcinoma is a safe and effective technique, with benefits such as reduced post-procedural pain and length of hospital stay, according to a study conducted by researchers from Changi General Hospital in Singapore.

Radiofrequency ablation of a liver tumor may be performed in a number of ways, said Hui Seong Teh, MD, lead author of the study. Two commonly used techniques are the percutaneous approach and open surgery. There have been few studies that compare the efficacy of the two methods, Dr. Teh says.

Article continues below and (thank you)

 

The study showed that the percutaneous approach is better tolerated by the patients, with significantly less post-procedural pain. Based on an objective scoring system, average pain score was 0.1 for patients who underwent the percutaneous technique, compared to 1.4 for those who had ablation performed with open laprotomy. Patients also have a much shorter stay in the hospital if they were treated using the percutaneous method, Dr. Teh says. The average length of stay in hospital was 2 days for patients who had the percutaneous method, compared to 10 days for those who had open RFA. The shorter length of hospital stay allows patients to resume their activity of daily living faster and enable their early return to active economy, says Dr. Teh.

"Our study further revealed an interesting finding in that the approaches used for ablation do not affect the effectiveness of the ablation treatment," Dr. Teh added. "The choice of RFA methods will affect the hospital resources spent on these patients, and will have a significant impact on healthcare cost," he said.

The full results of this study will be presented on Wednesday, May 9, 2007 during the American Roentgen Ray Society’s annual meeting in Orlando, FL.

 

Radiofrequency Ablation of Liver Tumors

 

 

Radiofrequency ablation needle devices that contain multiple curved, retractable electrodes. The electrodes are kept inside the needle until its tip is positioned within a tumor.

What is Radiofrequency Ablation of Liver Tumors?

Many methods of minimally invasive therapy have been tried in recent years to eliminate tumors in organs like the liver. One of the most promising is called radiofrequency ablation, sometimes referred to as RFA. A special needle electrode is placed in the tumor under the guidance of an imaging method such as ultrasound or computed tomography (CT) scanning. A radiofrequency current then is passed through the electrode to heat the tumor tissue near the needle tip and ablate—or eliminate—it. The heat from radiofrequency energy also closes up small blood vessels, thereby minimizing the risk of bleeding. In general, radiofrequency ablation causes only minimal discomfort and may be done as an outpatient procedure without general anesthesia. Admission to the hospital is not usually necessary.

What are some common uses of the procedure?

Two types of liver tumor have been the main targets of radiofrequency ablation: hepatocellular carcinoma, which is a primary liver cancer, and colon cancer that spreads (metastasizes) to the liver. Many patients with a malignant liver tumor are not good candidates for surgery, sometimes because their tumor is too widespread or inaccessible, or because of other medical conditions that make surgery especially risky. In other cases, so much liver tissue would have to be removed with the tumor that not enough would be left to provide adequate liver function. For many of these patients, radiofrequency ablation is a viable and effective treatment option.

Some liver tumors that have failed to respond to chemotherapy or have recurred after initial surgery may be treated by radiofrequency ablation. If there are multiple tumor nodules they may be treated in one or more sessions. In some cases radiofrequency ablation has made it possible to operate on a patient after eliminating several small liver tumors that were too spread out to remove surgically. In general, radiofrequency ablation is most effective if the tumor or tumors are less than two inches in diameter. Although radiofrequency ablation can be used to treat larger tumors, the results are not as good. Typically radiofrequency ablation is not used to treat liver tumors if there is active cancer outside of the liver.

How should I prepare for the procedure?

You will be asked to avoid food and liquids starting at midnight the evening before treatment. Your doctor will tell you which medications you may take in the morning. If you take aspirin, you may be instructed to stop 10 days beforehand. Consult your doctor if you are taking Coumadin or another blood thinner. If your doctor does not plan to admit you to the hospital overnight, you should arrive at the clinic with someone who will drive you home afterwards.

What does the equipment look like?

There are three main components of the equipment needed for radiofrequency ablation: needle electrodes, an electrical generator and grounding pads. The needle electrodes come in two forms: simple straight needles and straight needles that contain multiple curved, retractable electrodes that are kept inside the needle until its tip is positioned within a tumor. When properly positioned, a plunger on the hub of the needle is advanced so that the electrodes extend from the needle tip. When fully extended, these electrodes resemble an open umbrella or Christmas tree. The radiofrequency generator is connected by insulated wires to the needle electrodes and to grounding pads that are placed on the patient's back or thigh. The generator produces alternating electrical current in the range of radiofrequency waves.

How does the procedure work?

Radiofrequency ablation works by passing electrical current in the range of radiofrequency waves between the needle electrode and the grounding pads placed on the patient's skin. The current creates heat around the electrode inside the tumor and this heat spreads out to destroy the entire tumor but little of the surrounding normal liver tissue. Basically the tumor is destroyed by "cooking" it. The tumor cells exposed to the heat are killed immediately. Because healthy liver tissue withstands more heat than a tumor, radiofrequency ablation is able to destroy a tumor and a small rim of normal tissue about its edges without affecting most of the normal liver. The dead tumor cells are gradually replaced by scar tissue that shrinks over time.

How is the procedure performed?

Radiofrequency ablation may be done by placing ablation needles through the skin; by placing needles through a tube inserted through small holes in the skin (laparoscopy); or during open surgery. Most radiologists prefer the percutaneous (through-the-skin) approach because it is much less invasive, produces few complications and requires only sedation rather than general anesthesia. In addition, as an outpatient procedure it is relatively inexpensive. Radiofrequency ablation may be repeated as needed should the tumor recur. An ultrasound probe may be used as a "road map" to direct the radiofrequency needle to the correct position on the abdominal surface to reach the tumor, and then to the center of the tumor itself. Alternatively, CT imaging may serve the same purpose. Local anesthetic is injected into the site where a quarter-inch skin incision is planned, and the patient is sedated by an intravenous injection. Once the needle electrode is in place, radiofrequency energy is applied. For a larger tumor it may be necessary to do overlapping ablations to make certain that no tumor tissue is left behind.

What will I experience during the procedure?

Radiofrequency ablation is generally done in a room devoted to CT or ultrasound imaging. After you lie down on the examining table the tumor will be located and you will receive intravenous sedation (through a tube previously placed in an arm vein) to avoid discomfort during the procedure. You may or may not remain awake, depending on how deeply you are sedated. The skin area where the needle passes through will be numbed with local anesthetic to further decrease discomfort. Each radiofrequency ablation treatment takes about 12 to 30 minutes and the total procedure will be completed in one to three hours, depending on how many tumor sites have to be treated. After radiofrequency ablation you may receive further medication to prevent pain and nausea as the sedation wears off. Afterwards you will remain in the recovery room until totally awake and ready to leave for home. Only about 2 percent of patients will still have any degree of pain a week after radiofrequency ablation.

Organs and tissues near the liver, such as the gallbladder, bile ducts, diaphragm and bowel loops, are at risk of being injured. When this happens, surgical correction may be necessary. This only happens 3 percent to 5 percent of the time, however, and this risk is related to the location of the liver tumor that is treated.

Who interprets the results and how do I get them?

Most centers perform a CT or MRI scan of the liver within a few hours to a week after radiofrequency ablation to make certain that all tumor tissue has been destroyed, and also to detect any complications. A radiologist will interpret the CT or MRI scans and determine whether the entire liver tumor appears to have been eliminated. You will then have repeat CT scans every three months to check for new tumors.

What are the benefits vs. risks?

Benefits

  • Radiofrequency ablation can be an effective treatment for primary liver cancer or cancers that have spread to the liver in selected patients whose disease is unsuitable for surgical resection.
  • In most studies, more than half the liver tumors treated by radiofrequency ablation have not recurred.
  • Treatment-related serious complications are infrequent.
  • Radiofrequency ablation may be used repeatedly to treat recurrent liver tumors.
  • Radiofrequency ablation is a minimally invasive treatment that is rapidly completed and often does not require hospital admission. Patients are usually able to resume their usual activities within a few days. In addition, radiofrequency ablation is less expensive than other treatment options.

Risks

  • Depending on the site of treatment, radiofrequency ablation may cause brief or, rarely, long-lasting shoulder pain; inflammation of the gallbladder that subsides after a few weeks; damage to the bile ducts resulting in biliary obstruction; or thermal damage to the bowel.
  • Roughly one in four patients may develop a "post-ablation syndrome" with flu-like symptoms that appear three to five days after the procedure and usually last about five days. An occasional patient may remain ill for two to three weeks. Oral acetaminophen commonly is given to control fever.
  • Some cases of bleeding have been reported but it usually stops on its own. If bleeding is severe, an additional procedure or surgery may be needed to control it.

What are the limitations of Radiofrequency Ablation of Liver Tumors?

There is a limit to the volume of tumor tissue that can be eliminated by radiofrequency ablation. This is due to limitations in the size of the "burn" that can be produced with current equipment. Hopefully technical advances will permit larger tumors to be treated. Radiofrequency ablation can destroy many small liver tumors but will not eliminate microscopic-sized tumors and cannot prevent cancer from growing back.

To locate a medical imaging or radiation oncology provider in your community, you can search the ACR-accredited facilities database.

For more information on Interventional Radiology procedures, visit the Society of Interventional Radiology (SIR) Web site at http://www.sirweb.org.

Note About Links: For the convenience of our users, RadiologyInfo provides links to relevant Web sites. RadiologyInfo, ACR and RSNA are not responsible for the content contained on the Web pages found at these links.

This procedure is reviewed by a physician with expertise in the area presented and is further reviewed by committees from the American College of Radiology (ACR) and the Radiological Society of North America (RSNA), comprising physicians with expertise in several radiologic areas.

 

 

 
Google
Web www.iconocast.com
 
 
Continue News With: News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

 © 2002-2006

Keywords:

Contact Iconocast